Abstract:Glioblastoma multiforme (GBM) is a very aggressive and lethal primary brain cancer in adults. The multifaceted nature of GBM pathogenesis, rising from complex interactions between cells and the tumor microenvironment (TME), has posed great treatment challenges. Despite significant scientific efforts, the prognosis for GBM remains very poor, even after intensive treatment with surgery, radiation, and chemotherapy. Efficient GBM management still requires the invention of innovative treatment strategies. There is a strong necessity to complete cancer in vitro studies and in vivo studies to properly evaluate the mechanisms of tumor progression within the complex TME. In recent years, the animal models used to study GBM tumors have evolved, achieving highly invasive GBM models able to provide key information on the molecular mechanisms of GBM onset. At present, the most commonly used animal models in GBM research are represented by mammalian models, such as mouse and canine ones. However, the latter present several limitations, such as high cost and time-consuming management, making them inappropriate for large-scale anticancer drug evaluation. In recent years, the zebrafish (Danio rerio) model has emerged as a valuable tool for studying GBM. It has shown great promise in preclinical studies due to numerous advantages, such as its small size, its ability to generate a large cohort of genetically identical offspring, and its rapid development, permitting more time- and cost-effective management and high-throughput drug screening when compared to mammalian models. Moreover, due to its transparent nature in early developmental stages and genetic and anatomical similarities with humans, it allows for translatable brain cancer research and related genetic screening and drug discovery. For this reason, the aim of the present review is to highlight the potential of relevant transgenic and xenograft zebrafish models and to compare them to the traditionally used animal models in GBM research.

Advances in glioma models using in vivo electroporation to highjack neurodevelopmental processes

Advances in glioma therapy and its animal models

In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies

Glioma: experimental models and reality

Animal Models in Glioblastoma: Use in Biology and Developing Therapeutic Strategies

Modeling glioblastoma tumor progression via CRISPR-engineered brain organoids

In vivo mouse models for adult brain tumors: Exploring tumorigenesis and advancing immunotherapy development

From bedside to bench: New insights in epilepsy‐associated tumors based on recent classification updates and animal models on brain tumor networks

Translational Orthotopic Models of Glioblastoma Multiforme

Highlighting the Zebrafish Xenograft Model

Pediatric low-grade glioma models: advances and ongoing challenges

Pre-clinical models for evaluating glioma targeted immunotherapies

Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation

In vivo C6 glioma models: an update and a guide toward a more effective preclinical evaluation of potential anti-glioblastoma drugs

A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening

Glioblastoma preclinical models: Strengths and weaknesses

Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas

Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies

Understanding current experimental models of glioblastoma-brain microenvironment interactions

Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy

The Pathobiology of Glioma Tumors